MCM
LGND icon

McKinley Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

McKinley Capital Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-96,688
Closed -$6.16M – 539
2016
Q3 		$6.16M Sell
96,688
-64
-0.1% -$4.7K 0.22% 116
2016
Q2 		$7.2M Buy
96,752
+54
+0.1% +$4.01K 0.35% 94
2016
Q1 		$6.46M Buy
96,698
+29,184
+43% +$1.77M 0.31% 91
2015
Q4 		$4.57M Buy
+67,514
New +$4.17M 0.21% 128

Other funds holding LGND

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

McKinley Capital Management's LGND Position: Q4 2016 in Review

McKinley Capital Management sold out of Ligand Pharmaceuticals (LGND) in Q4 2016, closing a stake of 96,688 shares — an estimated $6.16M sold.

McKinley Capital Management first reported a position in LGND in Q4 2015 and held it in 4 quarters. The position peaked at $7.2M in Q2 2016. 269 funds tracked by Wall St. Rank hold LGND as of Q4 2016.

  • McKinley Capital Management reported no remaining Ligand Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • McKinley Capital Management sold 96,688 Ligand Pharmaceuticals shares in Q4 2016, an estimated $6.16M.
  • McKinley Capital Management first reported a position in Ligand Pharmaceuticals in Q4 2015 and held it in 4 quarters.
  • McKinley Capital Management's Ligand Pharmaceuticals position peaked at $7.2M in Q2 2016.
  • 269 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2016.

Based on McKinley Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.